CIK 0001631574 · Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-25 | BOLNO PAUL President and CEO | Sale 10b5-1 | −50,000 | $15.00 | $750K | 217,351 |
| 2024-11-25 | BOLNO PAUL President and CEO | Option exercise · Share Option (right to buy) 10b5-1 | −50,000 | 47,778 | ||
| 2024-11-15 | BOLNO PAUL President and CEO | Sale 10b5-1 | −51,234 | $14.32 | $734K | 217,351 |
| 2024-11-08 | Francis Chris See Remarks | Option exercise 10b5-1 | +36,000 | $8.17 | $294K | 36,000 |
| 2024-11-08 | Francis Chris See Remarks | Sale 10b5-1 | −36,000 | $16.00 | $576K | 0 |
| 2024-11-08 | Francis Chris See Remarks | Option exercise · Share Option (right to buy) 10b5-1 | −36,000 | 0 | ||
| 2024-10-16 | Francis Chris See Remarks | Sale 10b5-1 | −79,714 | $14.00 | $1.1M | 0 |
| 2024-10-16 | Francis Chris See Remarks | Option exercise 10b5-1 | +40,997 | $2.48 | $102K | 40,997 |
| 2024-10-16 | Francis Chris See Remarks | Sale 10b5-1 | −40,997 | $13.00 | $533K | 0 |
| 2024-10-16 | Francis Chris See Remarks | Option exercise 10b5-1 | +65,625 | $3.14 | $206K | 65,625 |
| 2024-10-16 | Francis Chris See Remarks | Sale 10b5-1 | −65,625 | $13.75 | $902K | 0 |
| 2024-10-16 | Francis Chris See Remarks | Option exercise 10b5-1 | +22,500 | $2.83 | $64K | 22,500 |
| 2024-10-16 | Francis Chris See Remarks | Sale 10b5-1 | −22,500 | $13.50 | $304K | 0 |
| 2024-10-16 | Francis Chris See Remarks | Option exercise · Share Option (right to buy) 10b5-1 | −40,997 | 0 | ||
| 2024-10-16 | Francis Chris See Remarks | Option exercise · Share Option (right to buy) 10b5-1 | −65,625 | 84,375 | ||
| 2024-10-16 | Francis Chris See Remarks | Option exercise · Share Option (right to buy) 10b5-1 | −22,500 | 22,500 | ||
| 2024-10-16 | BOLNO PAUL President and CEO | Sale 10b5-1 | −90,474 | $15.00 | $1.4M | 268,585 |
| 2024-10-11 | Moran Kyle Chief Financial Officer | Option exercise | +25,000 | $2.48 | $62K | 44,777 |
| 2024-10-11 | Moran Kyle Chief Financial Officer | Option exercise · Share Option (right to buy) | −25,000 | 0 | ||
| 2024-09-27 | GSK plc 10% owner | Purchase | +2,791,930 | $8.00 | $22.3M | 16,775,691 |
Page 10 of 13 · 255 trades